# Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO

> **NCT02091505** · NA · UNKNOWN · sponsor: **Mie University** · enrollment: 30 (estimated)

## Conditions studied

- Central Retinal Vein Occlusion

## Interventions

- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT02091505
- **Lead sponsor:** Mie University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2016-05
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02091505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02091505, "Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02091505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*